References
- 1. Kim DK, Jin HR, Eun KM et al. The role of interleukin-33 in chronic rhinosinusitis. Thorax. 2017; 72(7): 635-645.
- 2. Lam K, Schleimer R, Kern RC. The etiology and pathogenesis of chronic rhinosinusitis: a review of current hypotheses. Current allergy and asthma reports. 2015; 15(7): 41.
- 3. Lin H, Lin D, Xiong XS, et al. Expression and regulation of interleukin-9 in chronic rhinosinusitis. Am J Rhinol Allergy. 2015; 29(1): e18-23.
- 4. DeConde AS, Soler ZM. Chronic rhinosinusitis: Epidemiology and burden of disease. Am J Rhinol Allergy. 2016; 30(2): 134-9.
- 5. Beule A. Epidemiology of chronic rhinosinusitis, selected risk factors, comorbidities, and economic burden. GMS Current Topics in Otorhinolaryngology, Head and Neck Surgery. 2015; 14: Doc11.
- 6. Hastan D, Fokkens WJ, Bachert C et al. Chronic rhinosinusitis in European underestimated disease. A GA2LEN study. Allergy. 2011; 66(9): 1216-23.
- 7. Rudmik L. Economics of chronic rhinosinusitis. Curr Allergy Asthma Rep. 2017; 17(4) :20. doi: 10.1007/s11882-017-0690-5.10.1007/s11882-017-0690-5
- 8. Smith KA, Orlandi RR, Rudmik L. Cost of adult chronic rhinosinusitis: A systematic review.Laryngoscope. 2015; 125(7): 1547-56.
- 9. Cho S-W, Kim DW, Kim J-W et al. Classification of chronic rhinosinusitis according to a nasal polyp and tissue eosinophilia: limitation of current classification system for Asian population. Asia Pacific Allergy. 2017; 7(3): 121-130.
- 10. Kato A. Immunopathology of chronic rhinosinusitis. Allergology international: official journal of the Japanese Society of Allergology. 2015; 64(2): 121-130.
- 11. Cao PP, Li HB, Wang BF et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol. 2009; 124: 478-484. 484. e1-484.e2.
- 12. Fokkens WJ, Lund VJ, Mullol J et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012; 50(1): 1-12.
- 13. Li X, Tao Y, Li X. Expression of MMP-9/TIMP-2 in nasal polyps and its functional implications. International Journal of Clinical and Experimental Pathology. 2015; 8(11): 14556-14561.
- 14. Jabłońska-Trypuć A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem. 2016; 31(sup1): 177-183.
- 15. Bachert C, Pawankar R, Zhang L et al. ICON: chronic rhinosinusitis. The World Allergy Organization Journal. 2014; 7:25.
- 16. Bai X, Li YY, Zhang HY et al. Role of matrix metalloproteinase-9 in transforming growth factor-β1-induced epithelial–mesenchymal transition in esophageal squamous cell carcinoma. Onco Targets and therapy. 2017; 10: 2837-2847.
- 17. Lin CY, Tsai PH, Kandaswami CC et al. Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Sci. 2011; 102(4): 815-27.